Diagnosis and management of fetal growth restriction
- PMID: 21547092
- PMCID: PMC3087156
- DOI: 10.1155/2011/640715
Diagnosis and management of fetal growth restriction
Abstract
Fetal growth restriction (FGR) remains a leading contributor to perinatal mortality and morbidity and metabolic syndrome in later life. Recent advances in ultrasound and Doppler have elucidated several mechanisms in the evolution of the disease. However, consistent classification and characterization regarding the severity of FGR is lacking. There is no cure, and management is reliant on a structured antenatal surveillance program with timely intervention. Hitherto, the time to deliver is an enigma. In this paper, the challenges in the diagnosis and management of FGR are discussed. The biophysical profile, Doppler, biochemical and molecular technologies that may refine management are reviewed. Finally, a model pathway for the clinical management of pregnancies complicated by FGR is presented.
Figures


Similar articles
-
Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians.Eur J Obstet Gynecol Reprod Biol. 2015 Oct;193:10-8. doi: 10.1016/j.ejogrb.2015.06.021. Epub 2015 Jul 2. Eur J Obstet Gynecol Reprod Biol. 2015. PMID: 26207980
-
Fetal growth restriction - from observation to intervention.J Perinat Med. 2010 May;38(3):239-46. doi: 10.1515/jpm.2010.041. J Perinat Med. 2010. PMID: 20205623 Review.
-
Society for Maternal-Fetal Medicine Consult Series #52: Diagnosis and management of fetal growth restriction: (Replaces Clinical Guideline Number 3, April 2012).Am J Obstet Gynecol. 2020 Oct;223(4):B2-B17. doi: 10.1016/j.ajog.2020.05.010. Epub 2020 May 12. Am J Obstet Gynecol. 2020. PMID: 32407785
-
Fetal growth restriction: current knowledge.Arch Gynecol Obstet. 2017 May;295(5):1061-1077. doi: 10.1007/s00404-017-4341-9. Epub 2017 Mar 11. Arch Gynecol Obstet. 2017. PMID: 28285426 Review.
-
Evaluation and Management of Suspected Fetal Growth Restriction.Obstet Gynecol Clin North Am. 2021 Jun;48(2):371-385. doi: 10.1016/j.ogc.2021.02.007. Obstet Gynecol Clin North Am. 2021. PMID: 33972072 Review.
Cited by
-
CircTRNC18 inhibits trophoblast cell migration and epithelial-mesenchymal transition by regulating miR-762/Grhl2 pathway in pre-eclampsia.RNA Biol. 2019 Nov;16(11):1565-1573. doi: 10.1080/15476286.2019.1644591. Epub 2019 Jul 29. RNA Biol. 2019. PMID: 31354028 Free PMC article.
-
Role for the thromboxane A2 receptor β-isoform in the pathogenesis of intrauterine growth restriction.Sci Rep. 2016 Jul 1;6:28811. doi: 10.1038/srep28811. Sci Rep. 2016. PMID: 27363493 Free PMC article.
-
Placental adaptations in growth restriction.Nutrients. 2015 Jan 8;7(1):360-89. doi: 10.3390/nu7010360. Nutrients. 2015. PMID: 25580812 Free PMC article. Review.
-
Intrauterine growth restriction compromises cerebellar development by affecting radial migration of granule cells via the JamC/Pard3a molecular pathway.Exp Neurol. 2021 Feb;336:113537. doi: 10.1016/j.expneurol.2020.113537. Epub 2020 Nov 28. Exp Neurol. 2021. PMID: 33259808 Free PMC article.
-
Pregnancy-Related Extracellular Vesicles Revisited.Int J Mol Sci. 2021 Apr 9;22(8):3904. doi: 10.3390/ijms22083904. Int J Mol Sci. 2021. PMID: 33918880 Free PMC article. Review.
References
-
- Brar HS, Rutherford SE. Classification of intrauterine growth retardation. Seminars in Perinatology. 1988;12(1):2–10. - PubMed
-
- Bernstein I, Gabbe SG, Reed KL. Intrauterine growth restriction. In: Gabbe SG, et al., editors. Obstetrics: Normal and Problem Pregnancies. New York, NY, USA: Churchill Livingstone; 2002. p. 869.
-
- Barker DJP, Winter PD, Osmond C, Margetts B, Simmonds SJ. Weight in infancy and death from ischaemic heart disease. The Lancet. 1989;2(8663):577–580. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous